Peripheral kinin B1 and B2 receptor-operated mechanisms are implicated in neuropathic nociception induced by spinal nerve ligation in rats

Neuropharmacology

Volumn 53, Issue 1, 2007, Pages 48-57

  Werner, M F P ^a   Kassuya, C A L ^a   Ferreira, J ^b   Zampronio, A R ^c   Calixto, J B ^a   Rae, G A ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Cold allodynia; Heat hyperalgesia; Kinin B1 and B2 receptors; Neuropathic pain; Spinal nerve ligation; Tactile allodynia

Indexed keywords

ACETONE; BRADYKININ; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ[1-8]; BRADYKININ[8 LEUCINE 9 DEARGININE]; ICATIBANT; KININ B1 RECEPTOR; KININ B2 RECEPTOR; NEUROKININ 3 RECEPTOR; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; COLD INJURY; CONTROLLED STUDY; EVAPORATION; EVOKED RESPONSE; HEAT INJURY; HYPERALGESIA; MALE; NERVE LIGATION; NEUROPATHY; NOCICEPTION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSORY NERVE; SPINAL NERVE; WESTERN BLOTTING;

ANIMALS; BEHAVIOR, ANIMAL; BRADYKININ; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION ROUTES; FUNCTIONAL LATERALITY; HYPERALGESIA; LIGATION; MALE; NEURALGIA; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; SPINAL NERVES; TIME FACTORS;

EID: 34547205225     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.04.013     Document Type: Article

References (49)

1. Andre E., Ferreira J., Malheiros A., Yunes R.A., and Calixto J.B. Evidence for the involvement of vanilloid receptor in the antinociception produced by the dialdeydes unsaturated sesquiterpenes polygodial and drimanial in rats. Neuropharmacology 46 (2004) 590-597
2. Bautista D.M., Jordt S.E., Nikai T., Tsuruda P.R., Read A.J., Poblete J., Yamoah E.N., Basbaum A.I., and Julius D. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 124 (2006) 1269-1282
3. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
4. Blair S.J., Chinthagada M., Hoppenstehdt D., Kijowski R., and Fareed J. Role of neuropeptides in pathogenesis of reflex sympathetic dystrophy. Acta Orthop. Belg. 64 (1998) 448-451
5. Calixto J.B., Cabrini D.A., Ferreira J., and Campos M.M. Inflammatory pain: kinins and antagonists. Curr. Opin. Anaesthesiol. 14 (2001) 519-526
6. Calixto J.B., Medeiros R., Fernandes E.S., Ferreira J., Cabrini D.A., and Campos M.M. Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br. J. Pharmacol. 143 (2004) 803-818
7. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., and Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389 (1997) 816-824
8. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53 (1994) 55-63
9. Choi Y., Yoon Y.W., Na H.S., Kim S.H., and Chung J.M. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 59 (1994) 369-376
10. Cui J.G., Holmin S., Mathiesen T., Meyerson B.A., and Linderoth B. Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain 88 (2000) 239-248
11. Decosterd I., and Woolf C.J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87 (2000) 149-158
12. Dixon W.J. Efficient analysis of experimental observations. Ann. Rev. Pharmacol. Toxicol. 20 (1980) 441-462
13. Dray A., and Perkins M. Bradykinin and inflammatory pain. Trends Neurosci. 16 (1993) 99-104
14. Ferreira J., da Silva G.L., and Calixto J.B. Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice. Br. J. Pharmacol. 141 (2004) 787-794
15. Ferreira J., Beirith A., Mori M.A., Araujo R.C., Bader M., Pesquero J.B., and Calixto J.B. Reduced nerve injury-induced neuropathic pain in kinin B1 receptor knock-out mice. J. Neurosci. 25 (2005) 2405-2412
16. Fox A., Wotherspoon G., McNair K., Hudson L., Patel S., Gentry C., and Winter J. Regulation and function of spinal and peripheral neuronal B1 bradykinin receptors in inflammatory mechanical hyperalgesia. Pain 104 (2003) 683-691
17. Gougat J., Ferrari B., Sarran L., Planchenault C., Poncelet M., Maruani J., Alonso R., Cudennec A., Croci T., Guagnini F., Urban-Szabo K., Martinolle J.P., Soubrie P., Finance O., and Le Fur G. SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]pheny l)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization. J. Pharmacol. Exp. Ther. 309 (2004) 661-669
18. Griesbacher T., Amann R., Sametz W., Diethart S., and Juan H. The nonpeptide B2 receptor antagonist FR173657: inhibition of effects of bradykinin related to its role in nociception. Br. J. Pharmacol. 124 (1998) 1328-1334
19. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
20. Hudson L.J., Bevan S., Wotherspoon G., Gentry C., Fox A., and Winter J. VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. Eur. J. Neurosci. 13 (2001) 2105-2114
21. Julius D., and Basbaum A.I. Molecular mechanisms of nociception. Nature 413 (2001) 203-210
22. Katsura H., Obata K., Mizushima T., Yamanaka H., Kobayashi K., Dai Y., Fukuoka T., Tokunaga A., Sakagami M., and Noguchi K. Antisense knock down of TRPA1, but not TRPM8, alleviates cold hyperalgesia after spinal nerve ligation in rats. Exp. Neurol. 200 (2006) 112-123
23. Kim S.H., and Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
24. Kim K.J., Yoon Y.W., and Chung J.M. Comparison of three rodent neuropathic pain models. Exp. Brain Res. 113 (1997) 200-206
25. Koltzenburg M., Wall P.D., and McMahon S.B. Does the right side know what the left is doing?. Trends Neurosci. 22 (1999) 122-127
26. Lai J., Luo M.C., Chen Q., Ma S., Gardell L.R., Ossipov M.H., and Porreca F. Dynorphin A activates bradykinin receptors to maintain neuropathic pain. Nat. Neurosci. 9 (2006) 1534-1540
27. Levy D., and Zochodne D.W. Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain. Pain 86 (2000) 265-271
28. Ma Q.P. The expression of bradykinin B(1) receptors on primary sensory neurones that give rise to small caliber sciatic nerve fibres in rats. Neuroscience 107 (2001) 665-673
29. Marceau F., and Regoli D. Bradykinin receptor ligands: therapeutic perspectives. Nat. Rev. Drug Discov. 3 (2004) 845-852
30. McKemy D.D., Neuhausser W.M., and Julius D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 416 (2002) 52-58
31. Moalem G., and Tracey D.J. Immune and inflammatory mechanisms in neuropathic pain. Brain Res. Brain Res. Rev. 51 (2006) 240-264
32. Petersen M., Eckert A.S., Segond von Banchet G., Heppelmann B., Klusch A., and Kniffki K.D. Plasticity in the expression of bradykinin binding sites in sensory neurons after mechanical nerve injury. Neuroscience 83 (1998) 949-959
33. Petersen M., Segond von Banchet G., Heppelmann B., and Koltzenburg M. Nerve growth factor regulates the expression of bradykinin binding sites on adult sensory neurons via the neurotrophin receptor p75. Neuroscience 83 (1998) 161-168
34. Porreca F., Vanderah T.W., Guo W., Barth M., Dodey P., Peyrou V., Luccarini J.M., Junien J.L., and Pruneau D. Antinociceptive pharmacology of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-d imethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide, fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonist. J. Pharmacol. Exp. Ther. 318 (2006) 195-205
35. Rashid M.H., Inoue M., Matsumoto M., and Ueda H. Switching of bradykinin-mediated nociception following partial sciatic nerve injury in mice. J. Pharmacol. Exp. Ther. 308 (2004) 1158-1164
36. Seltzer Z., Dubner R., and Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43 (1990) 205-218
37. Shamash S., Reichert F., and Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J. Neurosci. 22 (2002) 3052-3060
38. Shen H., Chung J.M., and Chung K. Expression of neurotrophin mRNAs in the dorsal root ganglion after spinal nerve injury. Brain Res. Mol. Brain Res. 64 (1999) 186-192
39. Story G.M., Peier A.M., Reeve A.J., Eid S.R., Mosbacher J., Hricik T.R., Earley T.J., Hergarden A.C., Andersson D.A., Hwang S.W., McIntyre P., Jegla T., Bevan S., and Patapoutian A. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112 (2003) 819-829
40. Ueda H. Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms. Pharmacol. Ther. 109 (2006) 57-77
41. Wacnik P.W., Eikmeier L.J., Ruggles T.R., Ramnaraine M.L., Walcheck B.K., Beitz A.J., and Wilcox G.L. Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J. Neurosci. 21 (2001) 9355-9366
42. Walker K., Dray A., and Perkins M. Hyperalgesia in rats following intracerebroventricular administration of endotoxin: effect of bradykinin B1 and B2 receptor antagonist treatment. Pain 65 (1996) 211-219
43. Wang H., Ehnert C., Brenner G.J., and Woolf C.J. Bradykinin and peripheral sensitization. Biol. Chem. 387 (2006) 11-14
44. Woolf C.J., and Doubell T.P. The pathophysiology of chronic pain-increased sensitivity to low threshold A beta-fibre inputs. Curr. Opin. Neurobiol. 4 (1994) 525-534
45. Woolf C.J., and Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353 (1999) 1959-1964
46. Woolf C.J., and Salter M.W. Neuronal plasticity: increasing the gain in pain. Science 288 (2000) 1765-1769
47. Wotherspoon G., and Winter J. Bradykinin B1 receptor is constitutively expressed in the rat sensory nervous system. Neurosci. Lett. 294 (2000) 175-178
48. Yamaguchi-Sase S., Hayashi I., Okamoto H., Nara Y., Matsuzaki S., Hoka S., and Majima M. Amelioration of hyperalgesia by kinin receptor antagonists or kininogen deficiency in chronic constriction nerve injury in rats. Inflamm. Res. 52 (2003) 164-169
49. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110